Veedol [VEEDOL] vs Grauer & Weil [GRAUWEIL] Detailed Stock Comparison
Veedol
NSE
Loading...
Grauer & Weil
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Veedol wins in 10 metrics, Grauer & Weil wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Veedol | Grauer & Weil | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 15.36 | 28.26 | Veedol |
| Price-to-Book Ratio | 3.05 | 4.52 | Veedol |
| Debt-to-Equity Ratio | 2.40 | 1.26 | Grauer & Weil |
| PEG Ratio | 0.45 | -1.98 | Grauer & Weil |
| EV/EBITDA | 13.41 | 21.12 | Veedol |
| Profit Margin (TTM) | 9.04% | 13.35% | Grauer & Weil |
| Operating Margin (TTM) | 9.93% | 18.36% | Grauer & Weil |
| EBITDA Margin (TTM) | 9.93% | 18.36% | Grauer & Weil |
| Return on Equity | 18.46% | 16.74% | Veedol |
| Return on Assets (TTM) | 13.47% | 12.23% | Veedol |
| Free Cash Flow (TTM) | $-124.60M | $999.83M | Grauer & Weil |
| Dividend Yield | 3.20% | 1.05% | Veedol |
| 1-Year Return | -38.47% | -13.05% | Grauer & Weil |
| Price-to-Sales Ratio (TTM) | 1.39 | 3.77 | Veedol |
| Enterprise Value | $26.70B | $37.20B | Grauer & Weil |
| EV/Revenue Ratio | 1.33 | 3.31 | Veedol |
| Gross Profit Margin (TTM) | 42.47% | 58.14% | Grauer & Weil |
| Revenue per Share (TTM) | $1,180 | $25 | Veedol |
| Earnings per Share (Diluted) | $106.72 | $3.31 | Veedol |
| Beta (Stock Volatility) | 0.44 | 0.28 | Grauer & Weil |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Veedol vs Grauer & Weil Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Veedol | -0.63% | 1.34% | -2.55% | -3.09% | 8.83% | -0.86% |
| Grauer & Weil | -0.43% | 0.43% | -9.73% | 11.93% | 9.33% | -11.40% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Veedol | -38.47% | 45.57% | 79.27% | 102.11% | 283.26% | 1,609.03% |
| Grauer & Weil | -13.05% | 38.46% | 109.55% | 445.32% | 1,067.08% | 742.37% |
Performance & Financial Health Analysis: Veedol vs Grauer & Weil
| Metric | VEEDOL | GRAUWEIL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹27.90B | ₹42.42B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 9,486 | 110,802 |
| 90 Day Avg. Volume | 10,499 | 152,106 |
| Last Close | ₹1,639.30 | ₹93.25 |
| 52 Week Range | ₹1,305.00 - ₹2,800.00 | ₹78.00 - ₹120.00 |
| % from 52W High | -41.45% | -22.29% |
| All-Time High | ₹3,688.74 (Jul 12, 2021) | ₹204.80 (Feb 26, 2024) |
| % from All-Time High | -55.56% | -54.47% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.07% | -0.04% |
| Quarterly Earnings Growth | 0.34% | -0.14% |
| Financial Health | ||
| Profit Margin (TTM) | 0.09% | 0.13% |
| Operating Margin (TTM) | 0.10% | 0.18% |
| Return on Equity (TTM) | 0.18% | 0.17% |
| Debt to Equity (MRQ) | 2.40 | 1.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹537.84 | ₹20.72 |
| Cash per Share (MRQ) | ₹80.99 | ₹11.87 |
| Operating Cash Flow (TTM) | ₹720.80M | ₹1.68B |
| Levered Free Cash Flow (TTM) | ₹1.69B | ₹1.57B |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.20% | 1.05% |
| Last 12-Month Dividend | ₹54.00 | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Veedol vs Grauer & Weil
| Metric | VEEDOL | GRAUWEIL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 15.36 | 28.26 |
| Forward P/E | N/A | 37.57 |
| PEG Ratio | 0.45 | -1.98 |
| Price to Sales (TTM) | 1.39 | 3.77 |
| Price to Book (MRQ) | 3.05 | 4.52 |
| Market Capitalization | ||
| Market Capitalization | ₹27.90B | ₹42.42B |
| Enterprise Value | ₹26.70B | ₹37.20B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.33 | 3.31 |
| Enterprise to EBITDA | 13.41 | 21.12 |
| Risk & Other Metrics | ||
| Beta | 0.44 | 0.28 |
| Book Value per Share (MRQ) | ₹537.84 | ₹20.72 |
Financial Statements Comparison: Veedol vs Grauer & Weil
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VEEDOL | GRAUWEIL |
|---|---|---|
| Revenue/Sales | ₹5.14B | ₹2.53B |
| Cost of Goods Sold | ₹2.95B | ₹1.06B |
| Gross Profit | ₹2.18B | ₹1.47B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹510.10M | ₹464.90M |
| EBITDA | ₹720.90M | ₹653.10M |
| Pre-Tax Income | ₹637.20M | ₹584.00M |
| Income Tax | ₹140.50M | ₹147.90M |
| Net Income (Profit) | ₹496.70M | ₹436.10M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VEEDOL | GRAUWEIL |
|---|---|---|
| Cash & Equivalents | ₹430.80M | ₹1.08B |
| Total Current Assets | ₹8.13B | ₹9.36B |
| Total Current Liabilities | ₹2.70B | ₹2.97B |
| Long-Term Debt | ₹141.80M | ₹37.36M |
| Total Shareholders Equity | ₹9.14B | ₹9.39B |
| Retained Earnings | ₹8.21B | ₹283.32M |
| Property, Plant & Equipment | ₹286.80M | ₹211.61M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VEEDOL | GRAUWEIL |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | VEEDOL | GRAUWEIL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 9,486 | 110,802 |
| Average Daily Volume (90 Day) | 10,499 | 152,106 |
| Shares Outstanding | 16.99M | 453.41M |
| Float Shares | 6.06M | 127.47M |
| % Held by Insiders | 0.67% | 0.72% |
| % Held by Institutions | 0.02% | 0.00% |
Dividend Analysis & Yield Comparison: Veedol vs Grauer & Weil
| Metric | VEEDOL | GRAUWEIL |
|---|---|---|
| Last 12-Month Dividend | ₹54.00 | ₹1.00 |
| Last 12-Month Dividend Yield | 3.20% | 1.05% |
| 3-Year Avg Annual Dividend | ₹49.33 | ₹0.58 |
| 3-Year Avg Dividend Yield | 1.05% | 0.45% |
| 3-Year Total Dividends | ₹148.00 | ₹1.73 |
| Ex-Dividend Date | Jul 07, 2025 | Aug 06, 2025 |